Blood Pressure Med Recalls Cost Us Double, Payers Say

Law360 (January 31, 2019, 5:49 PM EST) -- A third-party health benefit payer is the latest entity to seek economic damages stemming from last year’s recalls of contaminated generic blood-pressure medicines, claiming it got stuck with the cost of replacement drugs for its members because the pharmaceutical companies put unsafe products on the market.

The Maine Automobile Dealers Association Inc. Insurance Trust is seeking recovery of the amount it and other third-party payers paid for replacement drugs and associated medical repercussions for their members the entire time the adulterated batches of Valsartan, Irbesartan and Losartan were sold, according to a suit filed Wednesday in New Jersey federal court....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS